Company profile: Sequent Medical
1.1 - Company Overview
Company description
- Provider of innovative catheter-based neurovascular technologies, including proprietary Microbraidβ’ technology used to create the WEBβ’ Aneurysm Embolization System for the treatment of neurovascular diseases.
Products and services
π
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Sequent Medical
Vernalis
HQ: United Kingdom
Website
- Description: Provider of fragment- and structure-based drug discovery, research collaborations with pharmaceutical, biotechnology and academic partners, and KNIME open-source software nodes for data access, cheminformatics and structural informatics; develops Chk1 and Hsp90 inhibitors. A revenue-generating development-stage pharmaceutical company advancing promising product candidates along a commercially focused path to market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Vernalis company profile β
Serina Therapeutics
HQ: United States
Website
- Description: Provider of proprietary polymer-based drug delivery and therapeutics, including the POZ Platform for programmable, targeted, continuous small-molecule delivery (IV/SC/IM); SER-252 for advanced Parkinsonβs Disease; CNS small-molecule conjugates; POZ-lipid LNPs for mRNA immunology; and ADCs that increase DAR to improve efficacy, addressing cancer, inflammation, pain and metabolic disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Serina Therapeutics company profile β
Brain Scientific
HQ: United States
Website
- Description: Provider of high-tech, clinical-grade neurological diagnostic devices designed to extend the reach and capability of telemedicine in neurology (teleneurology).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Brain Scientific company profile β
Cantabio Pharmaceuticals
HQ: United States
Website
- Description: Provider of preclinical biotechnology drug discovery research and therapeutic development focused on neurodegenerative and metabolic diseases, developing small-molecule DJ-1 protein-targeting therapeutics for Parkinsonβs and other conditions and Tau protein-targeting therapeutics for Alzheimerβs and related tauopathies, integrating biophysics and novel technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Cantabio Pharmaceuticals company profile β
Link Medicine
HQ: United States
Website
- Description: Provider of research aimed at creating disease-modifying therapies for neurodegenerative diseases, including Alzheimer's and Parkinson's disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Link Medicine company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Sequent Medical
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sequent Medical
2.2 - Growth funds investing in similar companies to Sequent Medical
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Sequent Medical
4.2 - Public trading comparable groups for Sequent Medical
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β